Abstract
ABSTRACT Massive doses of methotrexate, a folic acid inhibitor, followed by folinic acid, the specific antagonist, have been used to produce a period in which the embryo and foetus are exposed to tetrahydrofolate deficiency with subsequent inhibition of DNA synthesis. The effects of this inhibition vary at different stages of gestation, and in late foetal life provide a useful method of inducing a delay in the appearance of vertebral body ossification centres. This defect is rapidly repaired, although there may be permanent sequelae. It is hoped that this technique will be useful in the study of cellular events in ‘catch-up’ growth.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
